Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study

OBJECTIVES: Remdesivir is one of the most widely recommended and used medications for COVID-19 treatment. However, different outcomes have been reported for hospitalized patients with COVID-19 treated with remdesivir. Specifically, the effect of the timing of remdesivir initiation (from patient’s sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain Alsayed, Hawra Ali, Saheb Sharif-Askari, Fatemeh, Saheb Sharif-Askari, Narjes, Hussain, Ali Al Sayed, Hamid, Qutayba, Halwani, Rabih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547637/
https://www.ncbi.nlm.nih.gov/pubmed/34699552
http://dx.doi.org/10.1371/journal.pone.0258643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547637/
https://www.ncbi.nlm.nih.gov/pubmed/34699552
http://dx.doi.org/10.1371/journal.pone.0258643

Ejemplares similares